´ëÇÑ°£ÇÐȸ (¿Â¶óÀÎ) The Liver Week 2021 Virtual Confernence Day 2 : 2021-05-14±³À°ÀÏÀÚ : 2021-05-14
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) The Liver Week 2021 Virtual Confernence Day 2 ÁÖÃÖ±â°ü : ´ëÇÑ°£ÇÐȸ
´ã´çÀÚ : ´ëÇÑ°£ÇÐȸ Áغñ»ç¹«±¹
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ :
kaslsecretariat@hbni.co.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 24 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í Member-70,000/ Resident, Trainee, Fellow, Researcher, Army Doctor, Nurse, or Others-40,000 Non-Member, Healthcare Professional-110,000 International Delegate-USD 75 Foreign Investigator Award Winner-USD 40
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:20~08:40 Clinical Implication of Personalized Medicine in Hepatology Yeul Hong Kim(Korea Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:40~09:00 Personalized Medicine in NAFLD: From Genetics and Systems Biology Silvia Sookoian(Univ. of Buenos Aires Argentina)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Personalized Medicine in Liver Disease via Modulating the Gut Microbiota Ki Tae Suk(Hallym Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Personalized Medicine in Autoimmune Hepatitis Atsumasa Komori(National Hospital Organization Nagasaki Medical Center Japan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:10~11:35 To Be Confirmed Jeong-Hoon Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:35~12:00 Optimizing the Secondary Prevention of HCC in Patients with Chronic Hepatitis B: A Lesson from Real-World Evidence Jonggi Choi(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:00~12:30 To Be Confirmed Ju Dong Yang(Cedars-Sinai Medical Center USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Advancing Age and Comorbidity in Patients with Chronic Hepatitis B Yun Bin Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Hepatocellular Carcinoma Prediction Model for Antiviral-Treated Chronic Hepatitis B Patients Hwi Young Kim(Ewha Womans Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 Clinical Implications of Novel Biomarkers of Hepatitis B Virus Man-Fung Yuen(The Univ. of Hong Kong Hong Kong)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:30~14:50 HBV-Host Genome Integration: How Can We Detect It and What Is Its Impact? Thomas Tu(The Univ. of Sydney Australia)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:40 Progress and Challenges in Achieving Hepatitis B Virus Elimination Fabien Zoulim(National Institute for Health and Medical Research France)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:20 Acute-on-Chronic Liver Failure: Achievements and Future Perspectives Shiv Kumar Sarin(Institute of Liver & Biliary Science India)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:30~16:50 Individualized Risk Stratification of Compensated Advanced Chronic Liver Disease (cACLD) Annalisa Berzigotti(Univ. of Bern Switzerland)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:50~17:10 How to Prevent Decompensation in Compensated Cirrhosis Moon Young Kim(Yonsei Univ. Wonju)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:10~17:30 Current and Novel Treatment Strategies of Hepatic Encephalopathy Rajiv Jalan(Univ. College London UK)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:30~17:50 Understanding Coagulation and Hemostasis in Cirrhosis Jung Il Lee(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:20~08:40 LI-RADS Classification and Its Impact on the Prognosis of Primary Liver Cancer Sang Hyun Choi(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:40~09:00 Imaging Phenotype of Hepatocellular Carcinoma Subtypes Jin-Young Choi(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Different Hepatocellular Carcinoma Risk and Surveillance Strategies According to Situations: Young Age Nae-Yun Heo(Inje Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Different Hepatocellular Carcinoma Risk and Surveillance Strategies According to Situations: After Virologic Cure Jung Hyun Kwon(The Catholic Univ. of Korea)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:10~11:30 Role of Systemic Therapy in Intermediate-Stage Hepatocellular Carcinoma Masatoshi Kudo(Kindai Univ. Japan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:30~11:50 Role of Loco-Regional Treatment in Advanced-Stage Hepatocellular Carcinoma Ju Hyun Shim(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:50~12:10 Optimizing Radiotherapy with Immune Checkpoint Blockade in Hepatocellular Carcinoma Jeong Il Yu(Sungkyunkwan Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:10~12:30 Treatment of Advanced Hepatocellular Carcinoma with Child-Pugh B Cirrhosis Chang Wook Kim(The Catholic Univ. of Korea)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Selecting First-Line Therapy for Advanced Hepatocellular Carcinoma: TKI vs. ICI Kyung-Hun Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 How to Optimize Sequencing of Systemic Treatment in Advanced Hepatocellular Carcinoma Ann-Lii Cheng(National Taiwan Univ. Taiwan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 HCC Patients on Systemic Therapy: Prediction of Prognosis Beom Kyung Kim(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:30~14:50 Assessment of Tumor Response in Patients Receiving Systemic Therapy: RECIST 1.1, Modified RECIST or Other Options Min-Hee Ryu(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Expanding Criteria for Liver Transplantation: Sero-Positive Donors Hae Won Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 HCC Recurrence after Liver Transplantation: Risk Factors Wonseok Kang(Sungkyunkwan Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation: Surgery and Locoregional Therapy Dong-Hwan Jung(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:00~16:20 Management of Hepatocellular Carcinoma Recurrence after Liver Transplantation: Systemic Therapy Bo Hyun Kim(National Cancer Center Korea)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:20~08:40 ABO-Incompatible Living Donor Liver Transplantation and Biliary Complications Gi-Won Song(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:40~09:10 ABO-Incompatible Living Donor Liver Transplantation in High-Risk Patients: Hepatocellular Carcinoma and Infection Dong-Jin Joo(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:10~09:30 Optimal Protocol to Overcome Weak Points of ABO-Incompatible Living Donor Liver Transplantation Nam-Joon Yi(Seoul National Univ.)
Åä·Ð 05-14 ¿Â¶óÀÎ °³ÃÖ 09:30~09:40 Discussion ()
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:10~11:40 Post-Transplant Lymphoproliferative Disorder after Liver Transplantation Olivia Martinez(Stanford Univ. USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:40~11:50 Discussion ()
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:50~12:20 Outcome of Liver Retransplantation Using Living Donor Grafts Kaori Kuramitsu(Kobe Univ. Japan)
Åä·Ð 05-14 ¿Â¶óÀÎ °³ÃÖ 12:20~12:30 Discussion ()
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Preoperative Assessment of Liver Function in Patients Requiring Hepatectomy) Young Seok Han(Kyungpook National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Prevention of Post Hepatectomy Liver Failure (PHLF): Where Are We? (PVE, ALPPS, HVE, Ischemic Preconditioning) Albert Chan(The Univ. of Hong Kong Hong Kong)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 Early Detection of PHLF and Non-Surgical Management of PHLF Dong-Sik Kim(Korea Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:30~14:50 Timing and Results of Liver Transplantation for PHLF Pål-Dag Line(Univ. of Oslo Norway)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:20~08:40 Targeting cccDNA for Cure of Hepatitis B Virus Infection Kyun-Hwan Kim(Sungkyunkwan Univ)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 08:40~09:00 Unresolved Issues of Immune Tolerance in Chronic Hepatitis B: Earlier Treatment the Better? Hye Won Lee(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:00~09:20 Prognostic Impact of Concurrent Hepatic Steatosis in Chronic Hepatitis B: Can Lifestyle Modification Reduce HCC Risk? Yun Bin Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 09:20~09:40 Chemopreventive Strategies of HBV-related HCC: The Emerging Role of Non-viral Risk Factors Jonggi Choi(Univ. of Ulsan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:10~11:30 Introduction of the Useful Big Database for Researchers in NAFLD Donghee Kim(Stanford Univ. USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:30~11:50 MAFLD and Cardiovascular Disease Jian-Gao Fan(Shanghai Jiao Tong Univ. China)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 11:50~12:10 From NASH to Diabetes vs. from Diabetes to NASH: Different or Similar in Treatment? Yongho Lee(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 12:10~12:30 How NAFLD Patients Die: Heart, Liver, or Other Cancers? Jeong-Ju Yoo(Soonchunhyang Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:30~13:50 Update on Histopathology in Autoimmune Hepatitis Haeryoung Kim(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 13:50~14:10 Interpretation of Autoantibody Tests for Autoimmune Liver Diseases Yun-Jong Lee(Seoul National Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:10~14:30 Management of Difficult Cases of Autoimmune Hepatitis and New Therapeutics Atsumasa Komori(National Hospital Organization Nagasaki Medical Center Japan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 14:30~14:50 Update on Management of Primary Biliary Cholangitis Kyung-Ah Kim(Inje Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:00~15:20 Measurement of Hepatic Venous Pressure Gradient (HVPG) and Its Clinical Significance during TIPS or PARTO: Tips and Pitfalls Hitoshi Maruyama(Juntendo Univ. Japan)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:20~15:40 Application of HVPG for Predicting Prognosis in Liver Cirrhosis Young Chang(Soonchunhyang Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 15:40~16:00 Tailored Treatment of Cirrhotic Complications According to HVPG Jung Gil Park(Yeungnam Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:00~16:20 Non-Invasive Estimation of HVPG: Could It Be an Alternative? Young Seo Cho(Hanyang Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:30~16:50 Microbiome as a Potential Diagnostic Biomarker in Severe Alcoholic Hepatitis Soon Sun Kim(Ajou Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:50~17:10 Prognosis and Outcome of Patients with Alcohol-Associated Acute-On-Chronic Liver Failure Eileen L. Yoon(Hanyang Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:10~17:30 Clinical, Histological and Molecular Profiling of Different Stages of Alcohol-Related Steatohepatitis Ramon Bataller(Univ. of Pittsburgh USA)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:30~17:50 Non-Invasive Diagnostic Biomarkers in Alcohol-Related Liver Disease Young Kul Jung(Korea Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 16:30~17:05 Latest Treatment Drugs Hepatitis B, C and Treatment of Hepatitis D, E Wonseok Kang(Sungkyunkwan Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:05~17:40 Liver Transplantation with Renal Failure Man Ki Ju(Yonsei Univ.)
±³À°½Ã°£ 05-14 ¿Â¶óÀÎ °³ÃÖ 17:40~18:00 Latest Issues in the Liver Transplant Site Hyung Sook Kim(Seoul ST. Mary¡¯s Hospital)